New journal coming to touchIMMUNOLOGY soon!
touchREVIEWS in RMD. 2022;1(2):44–5 DOI: https://doi.org/10.17925/RMD.2022.1.2.44
Reducing the risk of rheumatic and musculoskeletal disease (RMD) is crucial to prevent associated chronic disease burden. However, the process is complex because the aetiopathological factors contributing to disease onset are not entirely understood. Healthy eating based on the Mediterranean diet (MD) can effectively prevent many chronic conditions and, potentially, RMD. Together with physical activity, […]
touchREVIEWS in RMD. 2022;1(1):7–8 DOI: https://doi.org/10.17925/RMD.2022.1.1.7
Living with inflammatory arthritis (IA) can pose multiple challenges throughout the lives of patients, as well as to their families and friends. Despite major advances in available treatments for inflammatory arthritides, such as rheumatoid arthritis and spondyloarthritis, there remains an important role for the person living with IA. In this regard, an important aspect of […]
touchREVIEWS in RMD 2022;1(1):23–8 DOI: https://doi.org/10.17925/RMD.2022.1.1.23
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) includes several distinct clinical entities: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA) and renal-limited vasculitis. What all these diseases have in common is the presence of serum autoantibodies, designated as ANCA, that react with antigens in the cytoplasm of neutrophilic granulocytes and monocytes.1,2 The […]
Get the latest clinical insights from touchIMMUNOLOGY